by 日経メディカル
日経メディカル Online（https://medical.nikkeibp.co.jp/）で毎週お送りするミニ特集（https://medical.nikkeibp.co.jp/inc/all/report/Weekly/）の見所を中心に、担当記者の生の声をお届けします。毎週月曜日に配信します。
Language
🇯🇵
Publishing Since
11/29/2021
Email Addresses
1 available
Phone Numbers
0 available
March 30, 2025
<p>2025年4月1日より、日経メディカル Online（https://medical.nikkeibp.co.jp/）の編集長が交代します。新編集長が抱負を語ります。</p><p><br /></p>
March 23, 2025
<p>2025年3月24日以降に日経メディカル Online（https://medical.nikkeibp.co.jp/）で配信する記事、および3月28日に配信予定のメールマガジン、週刊日経メディカルについて解説します。</p><p><br></p>
March 16, 2025
<p>2025年3月17日以降に日経メディカル Online（https://medical.nikkeibp.co.jp/）で配信する記事、および3月21日に配信予定のメールマガジン、週刊日経メディカルについて解説します。</p>
FERMONDO
日経メディカル
kodansha
COTEN inc.
プレジデント社
ナスとカイ
「週刊文春」編集部
NHK (Japan Broadcasting Corporation)
日本経済新聞社 マネーのまなび
SPINEAR
Chronicle
長まろ＆おが太郎
聴くテレ朝
ニッポン放送
IrohaniMoney
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.